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Introduction 
Traditionally, clinicians have evaluated symptoms indi-
vidually and in the context of the patient’s presentation 
in order to assess, triage, or diagnose.1–3 However, pa-
tients often experience multiple symptoms concurrently. 
Recently, researchers have examined symptoms incorpo-
rating the concept of clustering, defined as two or more 
symptoms that occur simultaneously and are related.4–6 
Examining symptom clusters may provide clinicians with 
a broader perspective in order to better understand how 
patients experience symptoms, which may guide clinical 
management.  
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Abstract 
Background: Although individual symptoms and symptom trajectories for various cardiovascular conditions have been 
reported, there is limited research identifying the symptom clusters that may provide a better understanding of pa-
tients’ experiences with heart disease. 
Aims: To summarize the state of the science in symptom cluster research for patients with acute coronary syndrome, 
myocardial infarction, coronary artery bypass surgery, and heart failure through systematic review and to provide di-
rection for the translation of symptom cluster research into the clinical setting. 
Methods: Databases were searched for articles from January 2000 through to May 2015 using MESH terms “symptoms, 
symptom clusters, acute coronary syndrome (ACS), myocardial infarction (MI), coronary heart disease (CHD), ischemic 
heart disease (IHD), heart failure (HF), coronary artery bypass surgery (CABS), cluster analyses, and latent classes.” The 
search was limited to human studies, English language articles, and original articles investigating symptom clusters 
in individuals with heart disease. Fifteen studies meeting the criteria were included. 
Results: For patients with ACS and MI, younger persons were more likely to experience clusters with the most symp-
toms. Older adults were more likely to experience clusters with the lowest number of symptoms and more diffuse 
and milder symptom clusters that are less reflective of classic ACS presentations. For HF patients, symptom clusters 
frequently included physical and emotional/cognitive components; edema clustered in only three studies. Symptom 
expression was congruent across geographical regions and cultures. 
Conclusions: The findings demonstrated similarities in symptom clusters during ACS, MI, and HF, despite multiple meth-
ods and analyses. These results may help clinicians to prepare at-risk patients for proper treatment-seeking and symp-
tom self-management behaviors. 
Keywords: Symptom clusters, symptoms, acute coronary syndrome, coronary heart disease, heart failure, myocardial 
infarction   
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Kirkova and colleagues suggested that the outcome or 
impact of a symptom cluster may be different or greater 
than the sum of individual symptoms.7 Although indi-
vidual symptoms and symptom trajectories for various 
cardiovascular conditions have been reported, there has 
been little translation of symptom cluster research in or-
der to inform clinical practice.2,3,8 For instance, knowledge 
of heart failure (HF) symptom clusters may help patients 
quickly recognize if their condition is deteriorating, thus 
decreasing the delay in seeking care, expediting treat-
ment, and preventing hospitalization.9 
Given the limited number of studies and varying ap-
proaches to symptom cluster research in cardiovascular 
populations, further examination of the concept of symp-
tom clusters is timely and warranted. Presently, it is un-
known whether individual symptoms are common or 
form a pattern across cardiac populations. There is specu-
lation that symptom clusters may share a common mecha-
nism, such as ischemia, or that symptoms within a cluster 
may respond to a single treatment.9 Further research can 
make a positive impact on clinical outcomes, but only af-
ter symptom clusters have been identified, examined, and 
understood within the context of ischemic cardiac dis-
ease. Therefore, the purpose of this systematic literature 
review was to summarize the state of the science in symp-
tom cluster research for patients with acute coronary syn-
drome (ACS), myocardial infarction (MI), coronary artery 
bypass surgery (CABS), and HF, and to provide direction 
for future research and potential translation of symptom 
cluster research into the clinical setting. 
Early symptom cluster research 
Researchers have hypothesized that clusters of symp-
toms could share common mechanisms, be related, or 
have similar influences on outcomes.10–12 For example, 
there are common biological mechanisms of psychoneu-
rological symptom clusters (depressive symptoms, cog-
nitive disturbance, fatigue, sleep disturbance, and pain) 
in patients with cancer.13 Yet few studies have examined 
the underlying mechanisms of individual symptoms or 
symptom clusters. 
Researchers have examined the impact of symptom 
clusters on patient outcomes, including quality of life 
(QOL), health status, functional limitations, symptom 
burden, and mortality.14–20 Poor QOL was associated with 
the presence of symptom clusters in patients with can-
cer,17,20 systemic symptom clusters in patients with leg ul-
cers,15 nausea and vomiting symptom clusters in cancer 
patients,18 and emotional/cognitive and physical symp-
tom clusters in multiple sclerosis (MS) patients.19 Func-
tional limitations were associated with a motor symptom 
cluster in patients with MS19 and among HF patients ex-
periencing both sickness behavior and discomforts of ill-
ness symptom clusters.16 A uremic symptom cluster pre-
dicted mortality for dialysis patients.14 
Symptom clusters have also been used to reduce the 
barriers to chronic obstructive pulmonary disease (COPD) 
self-management.21,22 Investigators have used symptom 
clusters to predict treatment choices for COPD23 and dem-
onstrated how symptom clusters could influence inter-
ventions.24 No outcome data are available to determine 
whether any of these symptom clusters were more robust 
than individual symptoms alone. 
Analytic techniques in symptom cluster research 
Researchers aiming to identify symptom clusters have 
used different instruments in order to query patients with 
cardiovascular disease about their symptoms, including 
instruments that have been previously discussed in the 
literature,25 general symptom inventories,9 disease-spe-
cific instruments,9,26,27 and instruments that have been val-
idated for the assessment of individual symptoms.28 In-
vestigators have also used several statistical methods in 
order to classify symptom clusters, including latent class 
analysis,29,30 the hierarchical cluster agglomerative ap-
proach,25,31 factor analysis,16 and model-based clustering 
methods.32 It remains unknown as to whether the use of 
different analytical techniques results in different symp-
tom clusters. 
Methods 
The investigation conforms with the principles outlined 
in the Declaration of Helsinki.33 
Data sources 
PubMed, CINAHL, MEDLINE, and Web of Science da-
tabases were searched for articles from January 2000 
through to May 2015 using a combination of the MESH 
terms “symptoms, symptom clusters, ACS, MI, ischemic 
heart disease (IHD), coronary heart disease (CHD), HF, 
CABS, cluster analyses, and latent classes.” The search 
was limited to human studies, those published in Eng-
lish, and original articles investigating symptom clusters 
in adults with heart disease. 
Study selection 
Descriptive or observational studies lack interventions, 
outcomes, and other study designs to consider when eval-
uating quality; therefore, we were unable to utilize the 
Cochrane criteria for systematic reviews of intervention 
guidelines or the Preferred Reporting Items for System-
atic Reviews and Meta-Analyses (PRISMA) of controlled 
trial guidelines for this systematic review.34,35 Instead, we 
were guided in study selection and evaluation by crite-
ria reported by Grimes and Schulz,36 who noted that de-
scriptive studies have several important roles in research, 
as the data are often the first venture into a line of inves-
tigation or a condition. This is the case with symptom 
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clusters in cardiovascular diseases. According to Grimes 
and Schulz,36 good descriptive research, similarly to re-
porting in the popular press, should include the five “W” 
questions – who, what, why, when, and where – with an 
implied sixth question – so what? For the purpose of this 
review, “who” represents the sample population; “what” 
represents the symptoms assessed; “why” represents the 
aims of the studies; “when” is the year of publication; and 
“where” represents the setting. Our “so what?” includes 
the interpretation of the findings and recommendations 
for future research. 
A total of 706 articles were identified in the search pro-
cess as potentially relevant. Abstracts were independently 
reviewed by the authors (blinded for review). Conflicts 
were resolved through discussions with all authors. An 
additional six articles were identified after hand-search-
ing reference lists. A literature search flowchart conform-
ing to PRISMA guidelines appears in Figure 1. Of these 
712 articles, 15 met the following inclusion criteria: (1) 
included samples of patients with ACS, MI, CABS, and 
HF; (2) assessed symptom clusters using any measure; 
and (3) analyzed symptom clusters using cluster statisti-
cal methods (factor analysis, latent class analysis, or hi-
erarchical cluster agglomerative analysis). Studies were 
excluded if: (1) single symptoms only were analyzed; or 
(2) aggregate data were reported without providing de-
tails of the symptoms in each cluster. ACS and MI studies 
were examined separately because the diagnosis of ACS 
includes patients with unstable angina. 
Results 
Data extraction 
Fifteen studies met the inclusion criteria. Nine studies 
met the criteria for the examination of symptom clus-
ters in ACS, MI, or CABS (Table 1). The aims of the stud-
ies were to classify groups of individuals with common 
symptom clusters. A variety of analytical methods were 
used, including cluster analysis, latent class analysis, and 
agglomerative hierarchical cluster analysis. The mean age 
of participants across studies was 64 years. Younger pa-
tients were more likely to be in clusters with the most 
symptoms.37,38 
Six studies were identified that examined symptom 
clusters in patients with HF. Four prospective studies 
used hierarchical cluster analysis in order to examine 
symptom clusters,26,27,39,40 while two studies used fac-
tor analysis.9,16 With one exception,27 all of the HF stud-
ies examined the relationships of symptom clusters with 
outcomes. 
A synthesis of the data is presented thematically. Sum-
maries of the findings from ACS, MI, and CABS popu-
lations appear in Table 1. Summaries of the findings 
from HF populations appear in Table 2. The individual 
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses literature search flowchart.
4 DeVon et  al .  in European Journal of  Cardiovascular Nurs ing  (2016) 
Systematic  rev iew of symptom clusters  in cardiovascular d isease   5
6 DeVon et  al .  in European Journal of  Cardiovascular Nurs ing  (2016) 
symptoms used for cluster analyses in each study are pre-
sented in Table 3. 
Cluster concepts 
Clustering can be conceptualized as groups of symptoms 
or groups of individuals clustered by personal character-
istics and symptoms.41 The studies were nearly evenly di-
vided between these two concepts. Important covariates, 
such as sex, age, and race, which influenced symptom 
cluster membership were included in the statistical anal-
ysis in most of the studies reported here.9,26,27,30,37–40 Age 
was significantly associated with cluster membership, 
with the youngest patients being more likely to be in the 
heavy symptom burden cluster in a study of 256 patients 
with ACS.35 Similarly to studies in ACS patients, sex and 
race were statistically significantly associated with clus-
ter membership in a study by Ryan et al.30 Age, race, body 
mass index (BMI), history of heart disease, diabetes, and 
smoking were associated with the clusters of symptoms 
in a cluster analysis study by McSweeney et al.38 Follow-
ing MI, younger, obese, diabetic black women reported 
the most acute symptoms, while older, non-obese, non-
diabetic White women reported the fewest. In a study of 
HF patients, age was the only predictor of membership in 
each of three clusters (odds ratio (OR) = 0.965–0.969, 95% 
confidence interval (CI) = 0.94–0.99, p ≤ 0.001), while dia-
betes was a significant predictor of the emotional cluster 
(OR = 0.644, 95% CI = 0.42–0.99, p = 0.046).9 
Study designs 
Most studies had cross-sectional, descriptive designs. Five 
were secondary data analyses,9,30,32,38,42 and one examined 
repeated measures at 6 weeks, 3 months, and 6 months 
following hospital discharge for CABS.42 In a large multi-
site study, Rosenfeld et al.29 examined symptom clusters 
in 874 patients evaluated in the emergency department 
for possible ACS; this was the only study in which symp-
toms were measured as they were occurring. 
Objectives of symptom cluster analyses 
There were many differences in the aims of the analy-
ses, with most ACS/MI studies focusing on classifying 
groups of individuals who shared clinical characteristics 
or common clusters of symptoms. Variations in symp-
tom clusters were evaluated by patients’ general physi-
cal and mental health, mood states, and QOL in a study 
of elders hospitalized for MI or CABS.31 The authors 
concluded that older adults experienced more diffuse 
and milder symptoms that were less reflective of classic 
ACS presentations. One year later, the same cohort was 
sampled in order to determine the frequency of cardiac 
symptoms and to determine whether the subgroups var-
ied based on QOL and psychological distress.25 Patients 
in the weary group had the poorest recovery outcomes, 
lower health-related QOL, and more psychological 
distress. 
Abbott et al.32 described cluster subgroups, determined 
if cluster subgroups varied by demographic and clinical 
characteristics, and examined the impact of symptom 
clusters on psychological functioning over time in 226 
patients who had undergone CABS. There was a signifi-
cant difference between patients in the low symptom bur-
den cluster group and those in the moderate symptom 
burden group: those is the low symptom burden group 
had higher physiological functioning and lower anxiety 
or depression. The investigators also found that, regard-
less of recovery time, cluster group membership was sig-
nificantly associated with mental scale scores. 
Zimmerman et al.42 examined the impact of the three 
patient clusters on physical functioning and physical ac-
tivity at 6 weeks, 3 months, and 6 months after surgery 
using data from the Abbott et al. study.32 All three groups 
improved in both physical functioning and physical activ-
ity over time. Riegel and colleagues43 examined symptom 
clusters, delay times, and outcomes in 331 individuals 
who had confirmed ACS. Riegel et al. also measured mor-
tality rates within two years of follow-up in an ACS co-
hort.43 Subjects in the diffuse symptom group (no highly 
represented symptoms) had higher mortality rates; how-
ever, this group was significantly older than the other 
groups, which may explain these differences. 
The ACS/MI studies mostly focused on identifying 
and describing symptom clusters in order to improve 
symptom assessment and reduce delays in seeking treat-
ment, while the HF studies attempted to tie clusters to 
the outcome variables of functional status, event-free sur-
vival, mortality, and hospital readmissions. 
Patient populations 
Symptom cluster studies were identified in cardiovas-
cular populations with four different diagnoses (ACS, 
MI, CABS, and HF), although most of the studies sam-
pled patients with ACS/MI and HF. Most of the studies 
were conducted with hospitalized patients (n = 9), and 
five studies (33%) enrolled patients in outpatient settings 
or by telephone. A total of 7104 patients were included in 
the 15 studies: 4321 inpatients, 2063 outpatients, and one 
study with a combination of inpatients and outpatients.27 
Sample sizes were generally large and varied from 11716 
to 1270.38 Three studies examined symptom clusters in in-
ternational populations.27,31,40 Moser et al.27 described and 
compared symptoms in 720 patients with HF from inpa-
tient and outpatient settings in three global regions — 
Asia (China and Taiwan), Europe (The Netherlands and 
Sweden), and the United States — in a cross-sectional, ob-
servation study. Congruence of symptom expression was 
found across cultures. Song et al.40 sampled 421 patients 
with HF exclusively in South Korea, and Ryan et al.30 in-
cluded a study conducted in England (n = 88). 
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Age 
Mean age ranged from 56 years16 to 76.3 years.31 The defi-
nition of older and younger patients varied between stud-
ies. Fukuoka and colleagues25 defined elderly as ≥65 years 
of age. McSweeney et al. defined younger as <50 years of 
age.38 DeVon et al. did not define younger and older, but 
the mean ages among four clusters ranged from 57 to 67.5 
years, with younger women more likely to be in the heavy 
symptom burden group.37 Similarly, the mean age ranges 
for four clusters in Rosenfeld et al.’s study were 54.8–65.4 
years, and younger patients were more likely to be in the 
heavy symptom burden cluster.29 
Number and type of symptoms entered into the 
cluster analysis 
The number of symptoms differed widely and ranged 
from 6 to 33. Most studies (n = 13) evaluated 6–14 symp-
toms; the mean number of symptoms evaluated was 11.3. 
Collectively, the most common symptoms measured were 
shortness of breath (n = 14), fatigue (n = 13), sleep distur-
bances (n = 10), swelling (n = 8), and depression (n = 7). 
Notably, all of the HF studies measured swelling, SOB, 
fatigue, and sleep disturbances; some type of pain was 
measured in all of the non-HF studies. Cognitive impair-
ment was measured only in the HF studies, while inci-
sional pain was measured solely in the CABS studies. In-
dividual symptoms appear in Table 3. 
Measures 
The use of a variety of multidimensional, multi-symp-
tom instruments in order to measure symptom clusters 
is evident in this review of the literature. These included 
a secondary analysis30; intensity of seven cardiac symp-
toms31; six of those seven symptoms in a follow-up25; the 
ACS Symptom Checklist29; responses to eight early recov-
ery (6 weeks and 3 months following surgery) symptoms 
from the Cardiac Symptom Survey32; and 14 symptoms 
generated from the REACT trial (seven symptoms)44 and 
from patients (seven symptoms).43 The volume and vari-
ation of instruments used in the studies make compari-
sons across studies challenging. 
In the nine ACS/MI/CABS studies evaluated, six 
different instruments were used. Two studies used the 
same instrument,32,42 and two29,37 used iterations of pre-
vious instruments. Herr and colleagues16 identified 
symptom clusters in HF patients, evaluating nine symp-
toms using seven different instruments. Jurgens et al.9 
analyzed the data of 687 patients from the Heart Fail-
ure Quality of Life Trial Collaborators registry in order 
to identify symptom clusters in patients who were hos-
pitalized with a confirmed diagnosis of acute HF. Nine 
symptoms from the Minnesota Living with Heart Fail-
ure Questionnaire (MLHFQ) were analyzed using fac-
tor analysis. 
Hertzog et al.39 used cluster analysis in order to iden-
tify patient subgroups with HF whose symptom patterns 
might help guide clinical management. Symptoms were 
measured with the Heart Failure Symptom Survey, which 
is a modified version of the Cardiac Symptom Survey. 
The instrument most commonly used in the HF stud-
ies was the MLHFQ. This instrument was used in acute 
to chronic HF patients and in an international study, al-
lowing some comparisons of clusters. In the Song et al. 
study,40 the presence and level of perceived distress of 
ten physical symptoms that are specific to HF reported 
for the previous 2 weeks were assessed using the Memo-
rial Symptom Assessment—Heart Failure questionnaire. 
Patients in the weary cluster who experienced more dis-
tress had a 50% higher risk of re-hospitalization within 1 
year of discharge.40 
Analytic techniques 
Some investigators analyzed clusters of symptoms using 
factor analysis32,38,42,43 and some grouped individuals ac-
cording to personal characteristics and common clus-
ters.25,29–31,37 Most studies (n = 6) used hierarchical clus-
ter agglomerative techniques; four used cluster analysis 
techniques; three used latent class; and two used factor 
analysis. Investigators used several statistical software 
programs, including SPSS, SAS, MPlus, and Latent Gold. 
Number of clusters 
The number of clusters across studies ranged from two to 
five. Only one study identified five clusters.30 The three 
studies that identified two clusters sampled patients with 
HF.26,27,40 The three studies that identified four clusters 
included ACS patients with classic-type clusters (chest 
symptoms) and less classic clusters. Most studies (n = 8) 
found three clusters. 
Cluster labels 
Researchers labeled symptoms by: (1) intensity or “bur-
den” (n = 3)32,39,42; (2) type, such as physiological or psy-
chosocial (n = 5)9,16,26,27,43; (3) a cross between intensity 
and specific symptoms (n = 7)25,29,30,37,38,40,43; and (4) as 
“typical,” “atypical,” or “classic” (n = 2).31,43 A number 
of investigators used the same labels in order to identify 
clusters such as “weary,”25,29,31,40 “diffuse,”25,43 “physical,” 
26,27 and “emotional/cognitive.”9,26,27 The terms “low,” 
“moderate,” and “heavy symptom burden” were com-
monly used across patient populations.29,32,37,39,42 
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Internal validity 
Some studies were well-powered and had large sample 
sizes, supporting the internal validity of their findings. 
For example, Ryan et al.30 completed a secondary data 
analysis of MI symptoms from nine different research 
studies (n = 1073) in order to identify the cluster of symp-
toms for AMI and to determine whether clusters were re-
lated to demographic groups. 
Discussion 
ACS, MI, and coronary bypass grafting 
The finding that younger patients were more likely to be 
in clusters with the most symptoms37,38 and older adults 
more likely to be in clusters with the fewest number of 
symptoms may hinder treatment-seeking and self-care 
behaviors. Older adults also experienced more diffuse 
and milder symptom clusters that are less reflective 
of a classic ACS presentation.29,30,37 These symptoms 
have been linked to poorer recovery, lower health-re-
lated QOL, more psychological distress,31 and higher 
mortality.43 
Classic29,43 and weary25,31 clusters were very common 
in ACS patients, and clinicians should be vigilant for more 
non-specific symptoms such as fatigue and sleep distur-
bances that may represent ACS, especially in older adults. 
Older adults tend to attribute symptoms as normal signs 
of aging, but should be counseled that most symptoms are 
not normal and should be evaluated. In addition, older 
adults who are at risk for CHD can be educated regard-
ing nonspecific symptoms and told about American Heart 
Association recommendations to call emergency services 
within 5 minutes of the onset of chest pain. Finally, be-
cause approximately 32% of patients with ACS do not ex-
perience chest pain,45 individuals with a history of CHD 
should be reminded that the symptoms of ACS are of-
ten vague and may be difficult to distinguish from other 
health problems. 
Heart failure 
HF symptom clusters frequently have physical and emo-
tional/cognitive components,26 reflecting the functional 
decline and cognitive impairment associated with HF.9 
Different investigators use different labels, but the indi-
vidual symptoms in the cluster are similar. For example, 
the label “sickness behaviors”16 contains nearly the same 
symptoms as the label “emotional/cognitive.”26,27 The 
label may be informative for other researchers, but, re-
gardless of labels, the information can be used to counsel 
patients regarding the importance of responding to multi-
ple symptoms that co-occur and may signal deterioration 
in their condition. Of the six HF studies, three used the 
MLHFQ, and all used multidimensional measures of 
symptoms. 
Clusters with the highest burden or severity of symp-
toms were related to higher New York Heart Associa-
tion (NYHA) class (greater physical impairment)39 and 
higher BMI.40 Higher levels of distress were correlated 
with worse outcomes, such as cardiac arrest.26 Higher 
levels of distress were also associated with increased re-
hospitalization independent of NYHA class, BMI, age, 
or sex.40 Notably, edema appeared in a symptom clus-
ter (discomforts of illness) in only one study of outpa-
tients,16 which included stable patients optimized on 
guideline-directed therapy. In two other studies, edema 
appeared in a cluster when the sample included patients 
with acute HF9 and in a sample in which 21% of patients 
were not prescribed diuretics.39 It is possible that edema 
was treated as a sign rather than a symptom in some 
studies, or was not perceived as stressful26 and conse-
quently underreported by patients. This requires fur-
ther research in order to determine whether this is clin-
ically relevant. 
Symptom clusters across international cohorts were 
reported in only one study, and no differences were 
found.27 Whether symptoms, symptom burden, or ex-
pression of symptoms vary across cultures requires fur-
ther research. Future research should examine potential 
mechanisms in order to determine whether symptom 
clusters are related from a biological perspective. In ad-
dition, whether symptom clusters change throughout 
the course of a disease (acute versus chronic phases) has 
not been investigated in cardiovascular populations. Fi-
nally, the impact of symptom clusters on patient out-
comes should be evaluated for all populations in order 
to determine whether symptom clusters add value to pa-
tient assessment and, if so, how to optimize symptom-
related interventions. 
Conclusions 
Differences in cluster concepts (clustering symptoms 
versus clustering groups of individuals with common 
symptom clusters), study design (retrospective versus 
prospective), sample characteristics (inclusion and exclu-
sion criteria and adjustment of confounders), measures 
(no standardized instruments and unidimensional ver-
sus multidimensional measures), and statistical analy-
ses make it challenging to compare results across studies 
and to generalize findings. None of the studies addressed 
the possible mechanisms of action explaining symptom 
clusters. Studies of all patient populations had long-term 
goals of developing interventions in order to improve pa-
tient outcomes.  
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